Found 25 matching trials
Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children N/A The objective of this study is to assess the TBE antibody persistence appro...
Show More Learn More & Join Trial
Primary TBE Vaccination for the Elderly PHASE4 Tick-borne Encephalitis (TBE) can be prevented by vaccine. Vaccine failure,...
Show More Location
Region Örebro Län
Learn More & Join Trial
FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years PHASE2 The purpose of this study is to investigate the safety and immunogenicity o...
Show More Location
Neuschwanstein Strasse 5
Learn More & Join Trial
FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years PHASE2 The purpose of this study is to investigate the safety and immunogenicity o...
Show More Location
Grieskirchner Strasse 17
Learn More & Join Trial
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy N/A The goal of this observational study is to learn about vaccine immunity in ...
Show More Location
University Hospital Bern
Learn More & Join Trial
TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209) PHASE4 The purpose of this study is to assess the seropersistence of TBE antibodie...
Show More Location
Grieskirchner Strasse 17
Learn More & Join Trial
FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years PHASE3 The aim of this study is to evaluate the safety of the third vaccination wi...
Show More Location
Zespol Opieki Zdrowotnej w Debicy
Learn More & Join Trial
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. PHASE2 The purpose of this study is to investigate the safety and immunogenicity o...
Show More Location
Grieskirchner Strasse 17
Learn More & Join Trial
Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years PHASE4 The objective of this study is to establish the earliest time point at whic...
Show More Location
SGS Biopharma Research Unit Stuivenberg
Learn More & Join Trial
Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun® PHASE4 FSME-Immun® is registered for application into the muscle. This study inves...
Show More Location
Multiple Locations
Learn More & Join Trial